News

Genetic variation boosts nicotine addiction risk

14-Jul-08

Young smokers are up to five times more likely to develop lifelong nicotine addictions if they have genetic variations affecting their nicotine receptors, US research suggests.

DNA samples were taken from 2,877 smokers in order to identify the occurrence of common single nucleotide polymorphisms, grouped into four haplotypes.

The researchers assessed the level of nicotine dependence for all smokers and recorded the age at which smoking began and the number of cigarettes smoked each day.

They found that people who began smoking before the age of 17 and possessed two copies of the high-risk haplotype for the nicotine receptors had from a 1.6-fold to 5-fold increased risk of heavy smoking as an adult.

For people who began smoking at the age of 17 or older, the presence of the high-risk haplotypes did not significantly influence their risk of later addiction.

The researchers, from the University of Utah and the University of Wisconsin, say that the study adds to recent advances showing how genetic variation can affect susceptibility to nicotine addiction.

sanjay.tanday@haymarket.com

PLOS Genetics Online 2008

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

There are problems with your form submission.

Please review the errors shown below.



Forgot your password?

Quick search - use * for an abbreviated search, eg nico*

 
 

Healthcare Republic Forums

 

Jobs

 

Job of the Week

Latest Clinical Articles

Abnormal uterine bleeding

Contributed by Mr Antonio V Antoniou, consultant gynaecologist and lead in minimal access surgery an... Read more

Chronic low back pain

Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Acute and sub-acute back pain

Contributed by Dr Mark Ritchie, GPSI in pain management, Morriston, Swansea Read more

Show all clinical articles

MIMS Product News

New drug - Stelara

Janssen-Cilag has launched Stelara for the treatment of moderate to severe plaque psoriasis where ot... Read more

New high-strength nicotine patch

Nicorette Invisipatch is the latest addition to the range of available nicotine replacement therapy ... Read more

Prolonged-release aspirin

Flamasacard, a prolonged-release formulation of aspirin, for secondary prophylaxis after a first cor... Read more